Differential expression and alternative splicing of genes in lumbar spinal cord of an amyotrophic lateral sclerosis mouse model

Brain Research

Volumn 1340, Issue , 2010, Pages 52-69

  Chen, Huifang ^a   Guo, Yansu ^a,b   Hu, Ming ^a   Duan, Weisong ^a,b   Chang, Geng ^a   Li, Chunyan ^a,b  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b Institute of Cardiocerebrovascular Disease   (China)

Author keywords

Amyotrophic lateral sclerosis; Cell adhesion; Exon array; Immune; Inflammation

Indexed keywords

ALTERNATIVE RNA SPLICING; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ADHESION; EXON; GENE EXPRESSION; GENETIC ANALYSIS; LIPID METABOLISM; LUMBAR SPINAL CORD; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UNINDEXED SEQUENCE;

ALTERNATIVE SPLICING; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; CELL ADHESION; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; LIPID METABOLISM; LUMBAR VERTEBRAE; METABOLIC NETWORKS AND PATHWAYS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NERVE TISSUE PROTEINS; PROTEIN ISOFORMS; SIGNAL TRANSDUCTION; SPINAL CORD;

ANIMALIA; MUS MUSCULUS;

EID: 77953122997     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2010.03.075     Document Type: Article

References (67)

1. Affymetrix Inc. Identifying and validating alternative splicing events. Affymetrix Technical Note (2006)
2. Andersen P.M. Amyotrophic lateral sclerosis genetics with Mendelian inheritance. In: Brown Jr. R.H., Swash M., and Pasinelli P. (Eds). Amyotrophic Lateral Sclerosis (2006), Informa Healthcare, London 187-207
3. Beckman J.S., Estevez A.G., Crow J.P., and Barbeito L. Superoxide dismutase and the death of motoneurons in ALS. Trends Neurosci. 24 (2001) S15-S20
4. Bruijn L.I., Miller T.M., and Cleveland D.W. Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu. Rev. Neurosci. 27 (2004) 723-749
5. Cayre M., Canoll P., and Goldman J.E. Cell migration in the normal and pathological postnatal mammalian brain. Prog. Neurobiol. 88 (2009) 41-63
6. Cleveland D.W., and Rothstein J.D. From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat. Rev. Neurosci. 2 (2001) 806-819
7. Dangond F., Hwang D., Camelo S., Pasinelli P., Frosch M.P., Stephanopoulos G., Stephanopoulos G., Brown Jr. R.H., and Gullans S.R. Molecular signature of late-stage human ALS revealed by expression profiling of postmortem spinal cord gray matter. Physiol. Genomics 16 2 (2004) 229-239
8. Di Giorgio F.P., Carrasco M.A., Siao M.C., Maniatis T., and Eggan K. Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model. Nat. Neurosci. 10 (2007) 608-614
9. Dupuis L., Corcia P., Fergani A., Gonzalez De Aguilar J.L., Bonnefont-Rousselot D., Bittar R., Seilhean D., Hauw J.J., Lacomblez L., Loeffler J.P., and Meininger V. Dyslipidemia is a protective factor in amyotrophic lateral sclerosis. Neurology 70 13 (2008) 1004-1009
10. Fergani A., Oudart H., Gonzalez De Aguilar J.L., Fricker B., René F., Hocquette J.F., Meininger V., Dupuis L., and Loeffler J.P. Increased peripheral lipid clearance in an animal model of amyotrophic lateral sclerosis. J. Lipid Res. 48 7 (2007) 1571-1580
11. Ferraiuolo L., Heath P.R., Holden H., Kasher P., Kirby J., and Shaw P.J. Microarray analysis of the cellular pathways involved in the adaptation to and progression of motor neuron injury in the SOD1 G93A mouse model of familial ALS. J. Neurosci. 27 34 (2007) 9201-9219
12. Freeman G.J., Long A.J., Iwai Y., Bourque K., Chernova T., Nishimura H., Fitz L.J., Malenkovich N., Okazaki T., Byrne M.C., Horton H.F., Fouser L., Carter L., Ling V., Bowman M.R., Carreno B.M., Collins M., Wood C.R., and Honjo T. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J. Exp. Med. 192 7 (2000) 1027-1034
13. Gardina P.J., Clark T.A., Shimada B., Staples M.K., Yang Q., Veitch J., Schweitzer A., Awad T., Sugnet C., Dee S., Davies C., Williams A., and Turpaz Y. Alternative splicing and differential gene expression in colon cancer detected by a whole genome exon array. BMC Genomics 7 (2006) 325
14. Gibson R.M., Craig S.E., Heenan L., Tournier C., and Humphries M.J. Activation of integrin alpha5beta1 delays apoptosis of Ntera2 neuronal cells. Mol. Cell. Neurosci. 28 (2005) 588-598
15. Goldknopf I.L., Sheta E.A., Bryson J., Folsom B., Wilson C., Duty J., Yen A.A., and Appel S.H. Complement C3c and related protein biomarkers in amyotrophic lateral sclerosis and Parkinson's disease. Biochem. Biophys. Res. Commun. 342 4 (2006) 1034-1039
16. Gonzalez N.C., and Wood J.G. Leukocyte-endothelial interactions in environmental hypoxia. Adv. Exp. Med. Biol. 502 (2001) 39-60
17. González-Scarano F., and Baltuch G. Microglia as mediators of inflammatory and degenerative diseases. Annu. Rev. Neurosci. 22 (1999) 219-240
18. Gurney M.E., Pu H., Chiu A.Y., Dal Canto M.C., Polchow C.Y., Alexander D.D., Caliendo J., Hentati A., Kwon Y.W., Deng H.X., et al. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science 264 (1994) 1772-1775
19. Hang X., Li P., Li Z., Qu W., Yu Y., Li H., Shen Z., Zheng H., Gao Y., Wu Y., Deng M., Sun Z., and Zhang C. Transcription and splicing regulation in human umbilical vein endothelial cells under hypoxic stress conditions by exon array. BMC Genomics 10 (2009) 126
20. Hensley K., Floyd R.A., Gordon B., Mou S., Pye Q.N., Stewart C., West M., and Williamson K. Temporal patterns of cytokine and apoptosis-related gene expression in spinal cords of the G93A-SOD1 mouse model of amyotrophic lateral sclerosis. J. Neurochem. 82 2 (2002) 365-374
21. Ince P.G., Lowe J., and Shaw P.J. Amyotrophic lateral sclerosis: current issues in classification, pathogenesis and molecular pathology. Neuropathol. Appl. Neurobiol. 24 (1998) 104-117
22. Ishida Y., Agata Y., Shibahara K., and Honjo T. Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. EMBO J. 11 11 (1992) 3887-3895
23. Ishigaki S., Niwa J., Ando Y., Yoshihara T., Sawada K., Doyu M., Yamamoto M., Kato K., Yotsumoto Y., and Sobue G. Differentially expressed genes in sporadic amyotrophic lateral sclerosis spinal cords-screening by molecular indexing and subsequent cDNA microarray analysis. FEBS Lett. 531 2 (2002) 354-358
24. Jiang Y.M., Yamamoto M., Kobayashi Y., Yoshihara T., Liang Y., Terao S., Takeuchi H., Ishigaki S., Katsuno M., Adachi H., Niwa J., Tanaka F., Doyu M., Yoshida M., Hashizume Y., and Sobue G. Gene expression profile of spinal motor neurons in sporadic amyotrophic lateral sclerosis. Ann. Neurol. 57 2 (2005) 236-251
25. Johnson J.M., Castle J., Garrett-Engele P., Kan Z., Loerch P.M., Armour C.D., Santos R., Schadt E.E., Stoughton R., and Shoemaker D.D. Genomewide survey of human alternative pre-mRNA splicing with exon junction microarrays. Science 302 5653 (2003) 2141-2144
26. King A.E., Dickson T.C., Blizzard C.A., Woodhouse A., Foster S.S., Chung R.S., and Vickers J.C. Neuron-glia interactions underlie ALS-like axonal cytoskeletal pathology. Neurobiol. Aging (2009) 10.1016/ j.neurobiolaging.2009.04.004
27. Kirby J., Halligan E., Baptista M.J., Allen S., Heath P.R., Holden H., Barber S.C., Loynes C.A., Wood-Allum C.A., Lunec J., and Shaw P.J. Mutant SOD1 alters the motor neuronal transcriptome: implications for familial ALS. Brain 128 Pt 7 (2005) 1686-1706
28. Kirkinezos I.G., Bacman S.R., Hernandez D., Oca-Cossio J., Arias L.J., Perez-Pinzon M.A., Bradley W.G., and Moraes C.T. Cytochrome c association with the inner mitochondrial membrane is impaired in the CNS of G93A-SOD1 mice. J. Neurosci. 25 1 (2005) 164-172
29. Lauriat T.L., Richler E., and McInnes L.A. A quantitative regional expression profile of EAAT2 known and novel splice variants reopens the question of aberrant EAAT2 splicing in disease. Neurochem. Int. 50 1 (2007) 271-280
30. Lederer C.W., Torrisi A., Pantelidou M., Santama N., and Cavallaro S. Pathways and genes differentially expressed in the motor cortex of patients with sporadic amyotrophic lateral sclerosis. BMC Genomics 8 (2007) 26
31. Lobsiger C.S., Boillée S., and Cleveland D.W. Toxicity from different SOD1 mutants dysregulates the complement system and the neuronal regenerative response in ALS motor neurons. Proc. Natl. Acad. Sci. U. S. A. 104 18 (2007) 7319-7326
32. Malaspina A., Kaushik N., and de Belleroche J. Differential expression of 14 genes in amyotrophic lateral sclerosis spinal cord detected using gridded cDNA arrays. J. Neurochem. 77 (2001) 132-145
33. Manfredi G., and Xu Z. Mitochondrial dysfunction and its role in motor neuron degeneration in ALS. Mitochondrion 5 (2005) 77-87
34. Marchetto M.C., Muotri A.R., Mu Y., Smith A.M., Cezar G.G., and Gage F.H. Non-cell-autonomous effect of human SOD1 G37R astrocytes on motor neurons derived from human embryonic stem cells. Cell Stem Cell 3 (2008) 649-657
35. McGeer P.L., and McGeer E.G. Inflammatory processes in amyotrophic lateral sclerosis. Muscle Nerve 26 4 (2002) 459-470
36. McKee A.E., Neretti N., Carvalho L.E., Meyer C.A., Fox E.A., Brodsky A.S., and Silver P.A. Exon expression profiling reveals stimulus-mediated exon use in neural cells. Genome Biol. 8 8 (2007) R159
37. Nielsen C., Ohm-Laursen L., Barington T., Husby S., and Lillevang S.T. Alternative splice variants of the human PD-1 gene. Cell. Immunol. 235 2 (2005) 109-116
38. Nishimura H., Nose M., Hiai H., Minato N., and Honjo T. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 11 (1999) 141-151
39. Nishimura H., Okazaki T., Tanaka Y., Nakatani K., Hara M., Matsumori A., Sasayama S., Mizoguchi A., Hiai H., Minato N., and Honjo T. Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science 291 (2001) 319-322
40. Offen D., Barhum Y., Melamed E., Embacher N., Schindler C., and Ransmayr G. Spinal cord mRNA profile in patients with ALS: comparison with transgenic mice expressing the human SOD-1 mutant. J. Mol. Neurosci. 38 2 (2009) 85-93
41. Olsen M.K., Roberds S.L., Ellbrock B.R., Fleck T.J., McKinley D.K., and Gurney M.E. Disease mechanisms revealed by transcription profiling in SOD1-G93A transgenic mouse spinal cord. Ann. Neurol. 50 (2001) 730-740
42. Pan Q., Shai O., Lee L.J., Frey B.J., and Blencowe B.J. Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat. Genet. 40 12 (2008) 1413-1415
43. Pasinelli P., and Brown R.H. Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Nat. Rev. Neurosci. 7 (2006) 710-723
44. Perrin F.E., Boisset G., Docquier M., Schaad O., Descombes P., and Kato A.C. No widespread induction of cell death genes occurs in pure motoneurons in an amyotrophic lateral sclerosis mouse model. Hum. Mol. Genet. 14 21 (2005) 3309-3320
45. Rabin S.J., Kim J.M., Baughn M., Libby R.T., Kim Y.J., Fan Y., Libby R.T., La Spada A., Stone B., and Ravits J. Sporadic ALS has compartment-specific aberrant exon splicing and altered cell-matrix adhesion biology. Hum. Mol. Genet. (2009) 10.1093/hmg/ddp498
46. Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., Donaldson D., Goto J., O'Regan J.P., and Deng H.X. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362 6415 (1993) 59-62
47. Sharpe A.H., Wherry E.J., Ahmed R., and Freeman G.J. The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat. Immunol. 8 3 (2007) 239-245
48. Shaw P.J. Molecular and cellular pathways of neurodegeneration in motor neurone disease. J. Neurol. Neurosurg. Psychiatry 76 8 (2005) 1046-1057
49. Simone R., Piatti G., and Saverino D. The inhibitory co-receptors: a way to save from anergy the HIV-specific T cells. Curr. HIV Res. 7 3 (2009) 266-272
50. Stritt C., Stern S., Harting K., Manke T., Sinske D., Schwarz H., Vingron M., Nordheim A., and Knöll B. Paracrine control of oligodendrocyte differentiation by SRF-directed neuronal gene expression. Nat. Neurosci. 12 (2009) 418-427
51. Suwan K., Choocheep K., Hatano S., Kongtawelert P., Kimata K., and Atanabe H. Versican/PG-M assembles hyaluronan into extracellular matrix and inhibits CD44-mediated signaling toward premature senescence in embryonic fibroblasts. J. Biol. Chem. 284 (2009) 8596-8604
52. Thorsen K., Sørensen K.D., Brems-Eskildsen A.S., Modin C., Gaustadnes M., Hein A.M., Kruhøffer M., Laurberg S., Borre M., Wang K., Brunak S., Krainer A.R., Tørring N., Dyrskjøt L., Andersen C.L., and Orntoft T.F. Alternative splicing in colon, bladder, and prostate cancer identified by exon-array analysis. Mol. Cell. Proteomics 7 7 (2008) 1214-1224
53. Tikka T.M., Vartiainen N.E., Goldsteins G., Oja S.S., Andersen P.M., Marklund S.L., and Koistinaho J. Minocycline prevents neurotoxicity induced by cerebrospinal fluid from patients with motor neurone disease. Brain 125 Pt 4 (2002) 722-731
54. Tsukita S., Furuse M., and Itoh M. Multifunctional strands in tight junctions. Nat. Rev. Mol. Cell Biol. 2 4 (2001) 285-293
55. Vargas M.R., Pehar M., Díaz-Amarilla P.J., Beckman J.S., and Barbeito L. Transcriptional profile of primary astrocytes expressing ALS-linked mutant SOD1. J. Neurosci. Res. 86 16 (2008) 3515-3525
56. Wang M.J., Kuo J.S., Lee W.W., Huang H.Y., Chen W.F., and Lin S.Z. Translational event mediates differential production of tumor necrosis factor-alpha in hyaluronan-stimulated microglia and macrophages. J. Neurochem. 97 (2006) 857-871
57. Wang X.S., Simmons Z., Liu W., Boyer P.J., and Connor J.R. Differential expression of genes in amyotrophic lateral sclerosis revealed by profiling the post mortem cortex. Amyotroph. Lateral Scler. 7 4 (2006) 201-210
58. Wang E.T., Sandberg R., Luo S., Khrebtukova I., Zhang L., Mayr C., Kingsmore S.F., Schroth G.P., and Burge C.B. Alternative isoform regulation in human tissue transcriptomes. Nature 456 7221 (2008) 470-476
59. Weydt P., Hong S.Y., Kliot M., and Möller T. Assessing disease onset and progression in the SOD1 mouse model of ALS. Neuroreport 14 7 (2003) 1051-1054
60. Wolburg H., Noell S., Wolburg-Buchholz K., Mack A., and Fallier-Becker P. Agrin, aquaporin-4, and astrocyte polarity as an important feature of the blood-brain barrier. Neuroscientist 15 (2009) 180-193
61. Wyss-Coray T., and Mucke L. Inflammation in neurodegenerative disease-a double-edged sword. Neuron 35 (2002) 419-432
62. Xi L., Feber A., Gupta V., Wu M., Bergemann A.D., Landreneau R.J., Litle V.R., Pennathur A., Luketich J.D., and Godfrey T.E. Whole genome exon arrays identify differential expression of alternatively spliced, cancer-related genes in lung cancer. Nucleic Acids Res. 36 20 (2008) 6535-6547
63. Yasojima K., Tourtellotte W.W., McGeer E.G., and McGeer P.L. Marked increase in cyclooxygenase-2 in ALS spinal cord: implications for therapy. Neurology. 57 6 (2001) 952-956
64. Yeo G.W., Xu X., Liang T.Y., Muotri A.R., Carson C.T., Coufal N.G., and Gage F.H. Alternative splicing events identified in human embryonic stem cells and neural progenitors. PLoS Comput. Biol. 3 10 (2007) 1951-1967
65. Yoshihara T., Ishigaki S., Yamamoto M., Liang Y., Niwa J., Takeuchi H., Doyu M., and Sobue G. Differential expression of inflammation- and apoptosis-related genes in spinal cords of a mutant SOD1 transgenic mouse model of familial amyotrophic lateral sclerosis. J. Neurochem. 80 (2002) 158-167
66. Zhang L., Lookene A., Wu G., and Olivecrona G. Calcium triggers folding of lipoprotein lipase into active dimers. J. Biol. Chem. 280 52 (2005) 42580-42591
67. Zhang Y.J., Xu Y.F., Cook C., Gendron T.F., Roettges P., Link C.D., Lin W.L., Tong J., Castanedes-Casey M., Ash P., Gass J., Rangachari V., Buratti E., Baralle F., Golde T.E., Dickson D.W., and Petrucelli L. Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity. Proc. Natl. Acad. Sci. U. S. A. 106 18 (2009) 7607-7612